365 related articles for article (PubMed ID: 11220665)
1. Lung cancer: chemoprevention and intermediate effect markers.
Tockman MS
IARC Sci Publ; 2001; 154():257-70. PubMed ID: 11220665
[TBL] [Abstract][Full Text] [Related]
2. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
[TBL] [Abstract][Full Text] [Related]
3. Clinical detection of lung cancer progression markers.
Tockman MS
J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
[TBL] [Abstract][Full Text] [Related]
4. Surrogate end-point biomarkers in chemopreventive drug development.
Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
[TBL] [Abstract][Full Text] [Related]
5. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
Kurie JM; Lee JS; Khuri FR; Mao L; Morice RC; Lee JJ; Walsh GL; Broxson A; Lippman SM; Ro JY; Kemp BL; Liu D; Fritsche HA; Xu X; Lotan R; Hong WK
Clin Cancer Res; 2000 Aug; 6(8):2973-9. PubMed ID: 10955773
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of lung cancer.
Hong WK
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):135-41. PubMed ID: 10550838
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
8. Molecularly targeted approaches to the chemoprevention of lung cancer.
Khuri FR; Cohen V
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4249s-4253s. PubMed ID: 15217968
[TBL] [Abstract][Full Text] [Related]
9. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.
Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170
[TBL] [Abstract][Full Text] [Related]
10. Retinoids: application in premalignant lesions and oral cancer.
Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
[TBL] [Abstract][Full Text] [Related]
11. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
Lippman SM; Benner SE; Hong WK
Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
[TBL] [Abstract][Full Text] [Related]
12. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
Niles RM
Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
[TBL] [Abstract][Full Text] [Related]
13. [Chemoprevention of lung cancer. A review about previous studies, results and future developments].
Heckmayr M
Pneumologie; 2004 Jun; 58(6):408-15. PubMed ID: 15216434
[TBL] [Abstract][Full Text] [Related]
14. Retinoids as cancer-preventive agents.
Sankaranarayanan R; Mathew B
IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of lung cancer: from concept to reality.
van Zandwijk N
Rocz Akad Med Bialymst; 2003; 48():5-10. PubMed ID: 14737934
[TBL] [Abstract][Full Text] [Related]
16. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
[TBL] [Abstract][Full Text] [Related]
17. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
Hecht SS
IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
[TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
19. The early detection of occult lung cancer.
Tockman MS; Mulshine JL
Chest Surg Clin N Am; 2000 Nov; 10(4):737-49. PubMed ID: 11091923
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer chemoprevention: an integrated approach.
Lippman SM; Spitz MR
J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
